Huakang Biomedical Holdings Balance Sheet Health
Financial Health criteria checks 3/6
Huakang Biomedical Holdings has a total shareholder equity of CN¥51.0M and total debt of CN¥2.8M, which brings its debt-to-equity ratio to 5.6%. Its total assets and total liabilities are CN¥65.3M and CN¥14.3M respectively.
Key information
5.6%
Debt to equity ratio
CN¥2.85m
Debt
Interest coverage ratio | n/a |
Cash | CN¥32.94m |
Equity | CN¥51.02m |
Total liabilities | CN¥14.30m |
Total assets | CN¥65.32m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8622's short term assets (CN¥53.4M) exceed its short term liabilities (CN¥13.1M).
Long Term Liabilities: 8622's short term assets (CN¥53.4M) exceed its long term liabilities (CN¥1.2M).
Debt to Equity History and Analysis
Debt Level: 8622 has more cash than its total debt.
Reducing Debt: 8622's debt to equity ratio has increased from 0% to 5.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 8622 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 8622 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.